Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07156357 · ClinicalTrials.gov registry record
Surface EMG Testing on Swallowing in EoE Patients
A clinical trial of Eosinophilic Esophagitis (EoE), sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT07156357: Recruiting study of Eosinophilic Esophagitis (EoE), sponsored by Mayo Clinic.
NCT07156357 is a study of Eosinophilic Esophagitis (EoE) that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 123-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07156357, a study of Eosinophilic Esophagitis (EoE), is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluating swallowing food with surface electromyography (EMG) machine in patients with Eosinophilic Esophagitis
Primary Outcome
Comparison of preparatory phase between cohorts
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Surface Electromyography
- DIAGNOSTIC_TEST Fiberoptic Endoscopic Evaluation of Swallowing
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-04 |
| Est. Completion | 2027-06 |
What NCT07156357 shows while recruiting
NCT07156357 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 123-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Eosinophilic Esophagitis (EoE) appearing as the primary indexed condition, and to 2 interventions - of which Surface Electromyography is the first listed.
NCT07156357 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07156357 about?
NCT07156357 is a clinical study titled "Surface EMG Testing on Swallowing in EoE Patients". Evaluating swallowing food with surface electromyography (EMG) machine in patients with Eosinophilic Esophagitis
What is the current status of trial NCT07156357?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-08-04. Estimated completion is 2027-06.
What conditions does trial NCT07156357 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis (EoE).
What interventions are being tested in trial NCT07156357?
The interventions under investigation include: Surface Electromyography (DIAGNOSTIC_TEST), Fiberoptic Endoscopic Evaluation of Swallowing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07156357?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07156357 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis (EoE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07156357's enrollment target sits among peer trials
30 9th of 10 higher than 1 of 10 other Eosinophilic Esophagitis (EoE) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis (EoE) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
RECRUITING
-
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
RECRUITING · Phase 4
-
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
RECRUITING · Phase 3
-
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
RECRUITING
-
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
ACTIVE NOT RECRUITING · Phase 2
-
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI